Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Debt Ratio (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 6 years of Debt Ratio data on record, last reported at 1.34 in Q3 2025.

  • For Q3 2025, Debt Ratio rose 105.38% year-over-year to 1.34; the TTM value through Sep 2025 reached 1.34, up 105.38%, while the annual FY2024 figure was 0.67, 32.44% up from the prior year.
  • Debt Ratio reached 1.34 in Q3 2025 per RANI's latest filing, up from 1.02 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.34 in Q3 2025 and bottomed at 0.0 in Q2 2022.
  • Average Debt Ratio over 5 years is 0.48, with a median of 0.46 recorded in 2023.
  • Peak YoY movement for Debt Ratio: tumbled 96.85% in 2021, then surged 121791.07% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.0 in 2021, then skyrocketed by 26499.1% to 0.27 in 2022, then skyrocketed by 88.01% to 0.51 in 2023, then surged by 32.44% to 0.67 in 2024, then soared by 98.72% to 1.34 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 1.34 in Q3 2025, 1.02 in Q2 2025, and 0.87 in Q1 2025.